Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
Suven Life Sciences Share Price
Suven Life Sciences Sha...
Suven Life Sci share price insights
Company has posted a loss of Rs 28.04 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Stock gave a 3 year return of 76.87% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)
Company's annual revenue growth of 49.28% outperformed its 3 year CAGR of 15.46%. (Source: Consolidated Financials)
Suven Life Sciences Ltd. share price moved down by -3.62% from its previous close of Rs 148.48. Suven Life Sciences Ltd. stock last traded price is 143.11
Share Price Value Today/Current/Last 143.11 Previous Day 148.48
Key Metrics
PE Ratio (x) | -28.62 | ||||||||||
EPS - TTM (₹) | -5.00 | ||||||||||
MCap (₹ Cr.) | 3,120.85 | ||||||||||
Sectoral MCap Rank | 60 | ||||||||||
PB Ratio (x) | 11.99 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 1.00 | ||||||||||
Beta Beta
| 1.14 | ||||||||||
VWAP (₹) | 143.59 | ||||||||||
52W H/L (₹) |
Suven Life Sci Share Price Returns
1 Day | -3.62% |
1 Week | -3.57% |
1 Month | 1.81% |
3 Months | 48.38% |
1 Year | 116.02% |
3 Years | 70.47% |
5 Years | -44.56% |
Suven Life Sci News & Analysis
NewsTurnaround story: 40 smallcaps that lost over 30% in FY23, turn multibaggers in FY24
News57 smallcap stocks deliver double-digit returns in a mixed market week
NewsAhead of Market: 10 things that will determine D-Street action on Wednesday
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcements
Suven Life Sci Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Suven Life Sci Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
PAT: Troublesome Times
Company has posted a loss of Rs 28.04 cr for the 4th consecutive quarter. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 49.28% outperformed its 3 year CAGR of 15.46%. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 5.01 6.67 8.52 8.20 9.44 Total Income Growth (%) -24.80 -21.70 3.84 -13.09 14.90 Total Expenses 33.03 34.18 50.25 20.84 33.48 Total Expenses Growth (%) -3.37 -31.97 141.11 -37.75 -6.50 EBIT -28.02 -27.51 -41.73 -12.64 -24.04 EBIT Growth (%) - - - - - Profit after Tax (PAT) -28.04 -26.54 -41.76 -12.68 -24.09 PAT Growth (%) - - - - - EBIT Margin (%) -558.73 -412.60 -489.99 -154.10 -254.74 Net Profit Margin (%) -559.19 -398.01 -490.41 -154.61 -255.28 Basic EPS (₹) -1.29 -1.22 -1.92 -0.58 -1.10 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 284.90 388.91 108.03 128.42 181.93 Total Assets Growth (%) -26.74 259.99 -15.87 -29.41 -40.03 Total Liabilities 14.86 13.59 11.89 20.41 38.58 Total Liabilities Growth (%) 9.35 14.32 -41.75 -47.10 -39.93 Total Equity 270.04 375.32 96.15 108.01 143.35 Total Equity Growth (%) -28.05 290.37 -10.98 -24.66 -40.05 Current Ratio (x) 18.99 22.61 8.01 6.45 2.49 Total Debt to Equity (x) 0.00 0.00 0.01 0.00 0.01 Contingent Liabilities - - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities -115.47 -103.15 -127.54 -96.02 -193.85 Net Cash used in Investing Activities 94.44 -260.65 -22.23 55.84 205.55 Net Cash flow from Financing Activities -1.05 395.54 145.69 34.86 2.74 Net Cash Flow -22.09 31.75 -4.07 -5.33 14.45 Closing Cash & Cash Equivalent 14.93 37.02 5.27 9.35 14.68 Closing Cash & Cash Equivalent Growth (%) -59.66 601.97 -43.59 -36.30 6,348.07 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 -0.01 All figures in Rs Cr, unless mentioned otherwise
Insights
Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -38.91 -31.51 -126.88 -66.80 -65.72 Return on Capital Employed (%) -41.77 -32.81 -121.80 -68.13 -68.10 Return on Assets (%) -36.88 -30.41 -112.92 -56.18 -51.78 Interest Coverage Ratio (x) -674.71 -406.21 -220.85 -94.01 -191.96 Asset Turnover Ratio (x) 0.03 0.03 0.04 10.49 7.92 Price to Earnings (x) -20.70 -8.94 -11.06 -12.42 -2.89 Price to Book (x) 8.05 2.82 14.02 8.30 1.90 EV/EBITDA (x) -18.81 -7.43 -11.47 -11.75 -2.54 EBITDA Margin (%) -914.01 -867.37 -988.42 -536.50 -705.39
Suven Life Sci Peer Comparison
Suven Life Sci Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 76.87% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 76.87% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 76.87% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 76.87% return as compared to Nifty Pharma which gave investors 64.81% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
Quant Business Cycle Direct-G
Equity: Thematic
20.85
Amount Invested (in Cr.)
1.38%
% of AUM
0.00
% Change (MoM basis)
Quant Healthcare Direct-G
Equity: Sectoral-Pharma
11.93
Amount Invested (in Cr.)
3.42%
% of AUM
0.00
% Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
0.01
Amount Invested (in Cr.)
0.08%
% of AUM
-8.66
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
Suven Life Sci Board Meeting/AGM
Suven Life Sci Dividends
- Others
Meeting Date Announced on Purpose Details Aug 05, 2024 Jul 29, 2024 Board Meeting Quarterly Results May 06, 2024 Apr 29, 2024 Board Meeting Audited Results Mar 07, 2024 Feb 02, 2024 POM - Jan 30, 2024 Jan 23, 2024 Board Meeting Quarterly Results Nov 04, 2023 Oct 27, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Interim 150% 1.5 Feb 14, 2019 Jan 29, 2019 Interim 150% 1.5 Feb 06, 2018 Jan 19, 2018 Interim 100% 1.0 Feb 08, 2017 Jan 23, 2017 Special 100% 1.0 Mar 14, 2016 Mar 08, 2016 Interim 100% 1.0 Mar 14, 2016 Mar 02, 2016 All Types Ex-Date Record Date Announced on Details Rights Oct 17, 2022 Oct 18, 2022 Jun 24, 2022 Rights ratio: 1 share for every 2 held at a price of Rs 55.0 Splits Mar 23, 2007 Apr 02, 2007 Jan 29, 2007 Split: Old FV2.0| New FV:1.0 Bonus Mar 23, 2007 Apr 02, 2007 Jan 29, 2007 Bonus Ratio: 1 share(s) for every 1 shares held Splits Jan 15, 2004 Jan 23, 2004 Dec 04, 2003 Split: Old FV10.0| New FV:2.0
About Suven Life Sci
Suven Life Sciences Ltd., incorporated in the year 1989, is a Mid Cap company (having a market cap of Rs 3,120.85 Crore) operating in Pharmaceuticals sector. Suven Life Sciences Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2024. Show More
Executives
Auditors
- VJ
Venkateswarlu Jasti
Chairman & Managing DirectorSJSudharani Jasti
Whole Time DirectorJAJ A S Padmaja
DirectorSMSantanu Mukherjee
DirectorShow More - Karvy & Co.Tukaram & Co. LLP
Industry
Key Indices Listed on
BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more
Address
8-2-334, SDE Serene Chambers,6th Floor, Avenue 7,Road No. 5, Banjara Hills,Hyderabad, Telangana - 500034
More Details
FAQs about Suven Life Sci share
- 1. What's Suven Life Sci share price today and what are Suven Life Sci share returns ?As on 29 Aug, 2024, 03:56 PM IST Suven Life Sci share price was down by 3.62% basis the previous closing price of Rs 155.07. Suven Life Sci share price was Rs 143.11. Return Performance of Suven Life Sci Shares:
- 1 Week: Suven Life Sci share price moved down by 3.57%
- 3 Month: Suven Life Sci share price moved up by 48.38%
- 6 Month: Suven Life Sci share price moved up by 39.76%
- 2. What is the PE & PB ratio of Suven Life Sci?The PE ratio of Suven Life Sci stands at -29.7, while the PB ratio is 11.99.
- 3. What's the market capitalization of Suven Life Sci?Suven Life Sci share has a market capitalization of Rs 3,120.85 Cr. Within Pharmaceuticals sector, it's market cap rank is 60.
- 4. What is Suven Life Sci's 52 week high / low?Suven Life Sci share price saw a 52 week high of Rs 161.00 and 52 week low of Rs 60.75.
- 5. What is the CAGR of Suven Life Sci?The CAGR of Suven Life Sci is -3.49.
- 6. Which are the key peers to Suven Life Sci?Within Pharmaceuticals sector Suven Life Sci, Dishman Carbogen Amcis Ltd., Indoco Remedies Ltd., Morepen Laboratories Ltd., Solara Active Pharma Sciences Ltd., SMS Pharmaceuticals Ltd., IOL Chemicals and Pharmaceuticals Ltd., Themis Medicare Ltd., Sequent Scientific Ltd., RPG Life Sciences Ltd. and Gufic BioSciences Ltd. are usually compared together by investors for analysis.
- 7. What are the Suven Life Sci quarterly results?Total Revenue and Earning for Suven Life Sci for the year ending 2024-03-31 was Rs 32.82 Cr and Rs -105.08 Cr on Consolidated basis. Last Quarter 2024-06-30, Suven Life Sci reported an income of Rs 5.01 Cr and loss of Rs -28.04 Cr.
- 8. What are the returns for Suven Life Sci share?Return Performance of Suven Life Sci Shares:
- 1 Week: Suven Life Sci share price moved down by 3.57%
- 3 Month: Suven Life Sci share price moved up by 48.38%
- 6 Month: Suven Life Sci share price moved up by 39.76%
- 9. What are the key metrics to analyse Suven Life Sci Share Price?Suven Life Sci share can be quickly analyzed on following metrics:
- Stock's PE is -28.62
- Price to Book Ratio of 11.99
- 10. Who's the owner of Suven Life Sci?
- Promoter holding has gone up from 69.57 (30 Sep 2023) to 70.27 (30 Jun 2024)
- Domestic Institutional Investors holding has gone up from 0.01 (30 Sep 2023) to 1.05 (30 Jun 2024)
- Foreign Institutional Investors holding have gone down from 0.5 (30 Sep 2023) to 0.45 (30 Jun 2024)
- Other investor holding have gone down from 29.92 (30 Sep 2023) to 28.23 (30 Jun 2024)
- 11. Who's the chairman of Suven Life Sci?Venkateswarlu Jasti is the Chairman & Managing Director of Suven Life Sci
- 12. Is Suven Life Sci giving dividend?Suven Life Sciences Ltd. announced an equity dividend of 150% on a face value of 1.0 amounting to Rs 1.5 per share on 29 Jan 2019. The ex dividend date was 14 Feb 2019.
Trending in Markets
Suven Life Sci Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.